Ramblings in Endocrine Biochemistry - PowerPoint PPT Presentation

1 / 50
About This Presentation
Title:

Ramblings in Endocrine Biochemistry

Description:

Ramblings in Endocrine Biochemistry. Pete Wood. To 'ramble' 'to go as fancy leads' 'to wander in mind or discourse' 'to be desultory, incoherent or delerious' ... – PowerPoint PPT presentation

Number of Views:259
Avg rating:3.0/5.0
Slides: 51
Provided by: Woo60
Category:

less

Transcript and Presenter's Notes

Title: Ramblings in Endocrine Biochemistry


1
Ramblings in Endocrine Biochemistry
  • Pete Wood

2
To ramble
  • to go as fancy leads
  • to wander in mind or discourse
  • to be desultory, incoherent or delerious
  • an irregular excursion
  • (Chambers)

3
Brief excursions
  • Life after Iodine 125
  • Cushings and salivary cortisol
  • Primary hyperaldosteronism
  • and 18-hydroxycortisol

4
Brief excursion 1
  • In house DELFIA assays

5
(No Transcript)
6
Assay Principle
  • Biotin-labelled detector antibody for
    immunometric assays
  • Biotin labelled steroid for competitive
    immunoassays
  • Detect with Europium labelled streptavidin

7
Antibody Biotinylation
  • 1 mg Ab onto PD10 desalting column
  • Elute with bicarb. Buffer
  • Add biotinamidocaproyl-NHS ester
  • 4o C overnight
  • PD10 desalting column - elute with Tris-HCl
  • Add purified BSA stabiliser

8
(No Transcript)
9
(No Transcript)
10
(No Transcript)
11
In-house DELFIA Salivary cortisol assay
12
In-house DELFIA assays
  • Steroids
  • Salivary cortisol
  • Salivary cortisone
  • Salivary 17 OHP
  • Plasma 17 OHP
  • Plasma and urine 18-hydroxycortisol
  • Peptides
  • Intact insulin ( 2 assays)
  • total proinsulin (for 32,33 split proinsulin)
  • intact proinsulin

13
Brief excursion 2
  • Cushings and salivary cortisols

14
(No Transcript)
15
(No Transcript)
16
Problems with Screening for Cushings Syndrome
  • Urine collections unreliable
  • Some cases suppress with low-dose dexamethasone
  • Cyclical Cushings

17
Cyclical Cushings
  • First described in 1971
  • 1985 Atkinson and co-workers
  • sequential urine samples collected in 9/14
    successive patients with Cushings syndrome
  • 5/9 had evidence of cyclical Cushings
  • 2 patients showed considerable variation without
    a cyclical pattern being established.

18
Cyclical Cushings
  • Definition - 3 peaks and two troughs
  • Cycle lengths 12 hours to 85 days

19
75 year-old lady
  • 12 kg weight loss and malaise
  • NIDDM diagnosed 18 months previously
  • Abdo CT - bilat. adrenal masses
  • Responded to empirical treatment with dexameth.
  • CT guided biopsy - adrenal hyperplasia
  • Centripetal weight distribution, prox. myopathy
  • No suppression of pl. cortisol to low and high
    dose dex ( 48 hrs each)
  • ACTH low but measurable (8-11 ng/L)
  • IPS/ CRH - 13/1 central/periph. gradient in ACTH
  • Transsphenoidal surgery - no adenoma identified

20
75 year-old lady (2)
  • High plasma cortisols persisted , but variable
  • 9 am and 10 pm salivary cortisols collected over
    a total of 19 days
  • 3 hour urines collected over 24 hours on three
    occasions

21
19 consec. days
22
75 year-old lady (3)
  • Plasma cortisol
  • Basal Peak
  • Test Meal 197 704
  • No meal - 278
  • 1ug CRH - 414
  • 1ug Synacthen - 647

23
75 year-old lady (4)
  • Bilateral adrenalectomy
  • Histology - bilateral macronodular hyperplasia
  • (AIMAH)
  • Why the false positive IPS/ CRH study ?
  • Why the initial features of hypoadrenalism ?

24
GIP - dependent Cushings
  • GIP Gastric Inhibitory Peptide
  • - now Glucose-dependent Insulinotrphic
    Polypeptide
  • Expression of GIP receptors in the adrenal
  • To date, identified in 17 patients with AIMAH,
  • and 7 patients with unilateral adenoma
  • not found in the adrenal cortex of normal
    subjects, fetuses, or in other forms of Cushings

25
Criteria - routine diagnostic salivary hormone
assays
  • Constant and predictable correlation must exist
    between salivary and serum hormone concentrations
  • Diagnostic value at least equal to serum hormone
    determinations
  • Single saliva samples as informative as single
    serum samples

26
(No Transcript)
27
(No Transcript)
28
(No Transcript)
29
Yaneva M et al JCEM 89 3345-3351 2004
30
Screening for Cushings syndrome
  • Sens/Spec ()
  • evening LDDST Combined
  • saliva
  • Raff et al 1998 92/95 - -
  • (N 39)
  • Castro et al 1999 93/93 91.4/94.4 100/93.3
  • (N 33)
  • Martinelli et al 1999 100/95.2 100/95.2 100/100
  • (N 11)
  • Yaneva et al 2004 100/96 - -
  • (N 63)

31
Findling and Raff JCEM 91(10) 3746-53 2006
32
Brief Excursion 3
  • Primary hyperaldosteronism
  • / 18-hydroxycortisol

33
Primary Hyperaldosteronism(PAL)
  • Adrenal adenoma ( Conn 1955 )
  • Familial hyperaldosteronism Type II
  • As part of MEN1
  • Adrenocortical carcinoma ( v. rare)
  • Bilateral adrenal hyperplasia
  • Glucocorticoid-Suppressible Hyperaldosteronism
    (GSH)
  • (Familial Hyperaldosteronism Type 1)

34
Primary Hyperaldosteronism
  • Conventionally thought to be less than 1 of
    patients with hypertension.
  • Recently, prevalence of 10 or more has been
    reported in hypertensives
  • Not all patients are hypokalaemic
  • Are we missing cases?

35
(No Transcript)
36
Prevalence of primary hyperaldosteronism
  • Stowasser and Gordon
  • (Trends in Endocrinol.Metab. 14 (7)310-317 2003)
  • Pre- A/R ratios Post
  • 1971-91 1992-99
  • N136 N592
  • Patients diagnosed/year 6.2 74.0
  • hypokalaemic 67 20
  • Conns adenoma 78 31.6
  • Hyperplasia 22 68

37
Screening
  • Aldosterone/ renin ratio ( ARR)
  • Morning ambulant sample
  • Do while on drugs and assess result in light of
    known drug effects
  • Ratio gt 25 ng/mU with aldo gt150 suggests primary
    hyperaldosteronism

38
Drug therapy and A/R ratios
  • A/R ratio
  • b-blockers ?(62) false ves
  • ACE inhibitors ?(-30)
  • AT receptor antag ?(-43
  • Ca Channel blockers ?(-17
  • Diuretics - OK
  • Spironolactone (?) false -ves BAH
  • (Seifarth et al, Clin.Endocrinol. 57 457-465 2002
  • Mulatero et al, Hypertension 40 897-902 2002)

39
Confirmatory Tests
  • Oral salt loading
  • Saline infusion
  • Fludrocortisone suppression test

40
Differentiating the subtypes
  • Questions
  • Does the patient have GSH / FH-1 ?
  • If GSH excluded, is autonomous aldo
  • production unilateral or bilateral ?

41
Unilateral vs bilateral
  • Adrenal CT unreliable
  • - fails to detect gt50 of adenomas
  • Posture response limited value
  • 50 of adenomas may be posture-responsive
  • 18- hydroxycortisol may also be normal in some
    posture responsive adenomas
  • Adrenal venous sampling best

42
(No Transcript)
43
(No Transcript)
44
18 - Hydroxy Cortisol A Hybrid Steroid
? in Conns adenoma and GSH, normal in BAH
45
(No Transcript)
46
(No Transcript)
47
Adenoma cell types
  • Aldo producing adenoma cell types can resemble
    ZG, ZF or ZR or hybrid ZF/ZG
  • One type of cell seems to predominate
  • If 80 non-ZF cells (ZG or hybrid), adenoma
    posture/ Angio II responsive
  • If 50-100 ZF cells, then adenoma is posture/
    Angio II unresponsive

48
(No Transcript)
49
Southampton FIA
24 hr Urine 18-hydroxy cortisol nmol/day
Conns adenoma
BAH
GSH
EH
50
Edinburgh RIA
24 hr urine 18-hydroxy cortisol (nmol/day)
Conns adenoma
BAH
GSH
EH
Write a Comment
User Comments (0)
About PowerShow.com